vimarsana.com

Page 32 - சிங்கப்பூர் ஜநரல் மருத்துவமனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

பிடோக் நார்த் வீட்டில் மின்சைக்கிள் தீ பிடித்தது; இருவர் மீட்பு

பிடோக் நார்த் வீட்டில் மின்சைக்கிள் தீ பிடித்தது; இருவர் மீட்பு
tamilmurasu.com.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tamilmurasu.com.sg Daily Mail and Mail on Sunday newspapers.

Man s death after fall of stretcher trolley during hospital transfer ruled medical misadventure

The Straits Times Man s death after fall of stretcher trolley during hospital transfer ruled medical misadventure The Coroner s report said CCTV footage showed the stretcher appeared to be pulled out steadily and the stretcher s collapse was sudden .ST PHOTO: LIM YAOHUI https://str.sg/Jy2K They can read the article in full after signing up for a free account. Share link: Or share via: Sign up or log in to read this article in full Sign up All done! This article is now fully available for you Read now Get unlimited access to all stories at $0.99/month for the first 3 months.

CAR-T therapy leads Singapore medical tourism within APAC

CAR-T therapy leads Singapore medical tourism within APAC 12 April 2021 | Analysis With the approval of Novartis’ Kymriah, Singapore is becoming a popular medical tourism destination within APAC: says GlobalData Photo Credit: GlobalData The inherent heterogeneity of diseases such as cancer is driving the field of personalized (precision) therapies. Within personalized therapies, chimeric antigen receptor (CAR-T) therapies are gaining traction. With the approval of Novartis’ Kymriah, Singapore is now all set to deliver the transformative treatment for cancers and takes the lead in medical tourism within Asia-Pacific (APAC), says GlobalData, a leading data and analytics company. In March 2021, Novartis received approval for Kymriah for adult r/r diffuse large B-cell lymphoma DLBCL (DLBCL) patients and young adult r/r B-cell acute lymphoblastic leukemia (ALL) patients. Kymriah will be the first CAR-T therapy to be approved in Southeast Asia.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.